Cantor Fitzgerald Initiates Coverage On Structure Therapeutics with Overweight Rating, Announces Price Target of $65
Portfolio Pulse from Benzinga Newsdesk
Cantor Fitzgerald analyst Prakhar Agrawal has initiated coverage on Structure Therapeutics (NASDAQ:GPCR) with an Overweight rating and set a price target of $65.
April 09, 2024 | 11:03 am
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Structure Therapeutics receives an Overweight rating from Cantor Fitzgerald with a price target of $65.
The initiation of coverage by a reputable analyst firm like Cantor Fitzgerald with an Overweight rating and a high price target usually signals strong confidence in the company's future performance. This can lead to increased investor interest and potentially a rise in stock price in the short term.
CONFIDENCE 95
IMPORTANCE 90
RELEVANCE 100